Microphysiological systems offer a promising solution to the long-standing challenge of predicting clinical drug safety outcomes from preclinical models.
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.